What Are the Penalties for Illegally Prescribing Ketamine
Ketamine’s Schedule III classification produces a different mandatory minimum structure than the Schedule II opioids at the center of most opioid fraud prosecutions. That difference is practically significant and is one of the most important distinctions between ketamine diversion prosecutions and opioid diversion prosecutions.
The penalties for distribution of a Schedule III controlled substance outside the usual course of professional practice under 21 U.S.C. 841 reflect the statutory penalty structure for Schedule III substances rather than the more severe structure applicable to Schedule II. The maximum sentence for a first offense involving a Schedule III substance is ten years imprisonment, compared to twenty years for Schedule II substances. Critically, Schedule III offenses generally do not carry the drug quantity mandatory minimums that apply to Schedule II opioid offenses and that have produced some of the most severe sentences in opioid fraud prosecutions.
The Schedule III Penalty Structure
For a first offense involving distribution of a Schedule III controlled substance, the maximum sentence is ten years imprisonment and a fine of up to five hundred thousand dollars. For a second offense, the maximum increases to twenty years. The absence of drug quantity mandatory minimums for Schedule III substances means that the sentencing court has substantially more discretion to impose a sentence below the statutory maximum than is available in Schedule II cases where mandatory minimums establish a floor.
The guidelines calculation for a Schedule III controlled substance distribution offense is driven by the offense level, which is determined by the drug quantity converted to marijuana equivalents using the DEA’s conversion table. The marijuana equivalent conversion for ketamine is significantly less than the equivalent conversion for Schedule II opioids, meaning that a practitioner who administered or distributed a given quantity of ketamine faces a lower guidelines offense level than a practitioner who prescribed the same dollar value of opioids.
Healthcare Fraud Penalties
Where ketamine prescribing or administration is connected to fraudulent billing of federal healthcare programs, the healthcare fraud statute at 18 U.S.C. 1347 applies independently of the Schedule III controlled substance framework. Healthcare fraud carries a maximum sentence of ten years, increasing to twenty years if serious bodily injury results and to life imprisonment if death results. The healthcare fraud charges are not subject to the drug quantity mandatory minimum structure and are driven by the guidelines calculation for financial fraud offenses, including the loss table that reflects the amount fraudulently billed.
Need Help With Your Case?
Don't face criminal charges alone. Our experienced defense attorneys are ready to fight for your rights and freedom.
- 100% Confidential
- Response Within 1 Hour
- No Obligation Consultation
Or call us directly:
(212) 300-5196The combination of Schedule III drug distribution charges with healthcare fraud charges produces a guidelines calculation that uses whichever offense produces the higher offense level. In cases where the fraudulent billing amount is substantial, the healthcare fraud guidelines may produce a higher offense level than the drug distribution guidelines, and the sentencing exposure reflects the healthcare fraud calculation rather than the drug quantity.
Administrative Penalties
Independent of the criminal sentencing framework, illegal ketamine prescribing may result in the revocation of the practitioner’s DEA registration, which eliminates the ability to prescribe any controlled substance. The administrative penalty of registration revocation is available to the DEA regardless of whether criminal charges are filed and regardless of the specific drug schedule involved. The practitioner who loses their DEA registration cannot prescribe ketamine, opioids, or any other controlled substance and may be effectively excluded from clinical practice in specialties that require controlled substance prescribing authority.
Todd Spodek
Lead Attorney & Founder
Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.
The Schedule III classification of ketamine produces a more favorable penalty structure than Schedule II opioid offenses in one specific respect: the absence of drug quantity mandatory minimums. In every other respect, the legal exposure for illegal ketamine prescribing is severe: federal criminal prosecution, DEA registration revocation, state medical license proceedings, and, where billing fraud is involved, False Claims Act civil liability. The penalty structure is more favorable, not benign.
The Death-Resulting Enhancement
The most severe sentence enhancement in the ketamine context is the death-resulting enhancement under 21 U.S.C. 841(b)(1)(C), which provides that if death or serious bodily injury results from the use of any substance distributed in violation of the statute, the offender shall be sentenced to a term of imprisonment of not less than twenty years. This mandatory minimum applies regardless of the drug’s schedule and creates a twenty-year floor in any ketamine distribution case where the distributed ketamine caused a patient death. The clinical monitoring protocols that identify and prevent adverse ketamine outcomes serve a legal defense function, in addition to their clinical function, by creating a record that the death was not a foreseeable result of the prescribing.